SLC12A5 and central nervous system cancer: In this study, we discovered a potassium‐chloride co‐transporter SLC12A5 with altered genome architecture between HA1800 and A172, which is downregulated in high‐grade glioma and also as a protective factor contributed to outcome of patients.